LILRB2 and systemic lupus erythematosus: We found that a very high percentage of mDC from healthy controls expressed ILT4; in contrast, mDC from SLE patients showed a significant lower expression of the inhibitory receptor (p = 0.018, Figures 1(b) and 1(c)).